U.K. Biotech Stocks

AstraZeneca

Market Cap: UK£173.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£59.8b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£29.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Genus

Market Cap: UK£1.5b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Oxford Biomedica

Market Cap: UK£699.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

PureTech Health

Market Cap: UK£306.5m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Animalcare Group

Market Cap: UK£172.5m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Diaceutics

Market Cap: UK£135.4m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Bioventix

Market Cap: UK£130.6m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Shield Therapeutics

Market Cap: UK£78.4m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

hVIVO

Market Cap: UK£54.8m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

SkinBioTherapeutics

Market Cap: UK£42.4m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Arecor Therapeutics

Market Cap: UK£27.4m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Tissue Regenix Group

Market Cap: UK£16.7m

A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.

ProBiotix Health

Market Cap: UK£12.3m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Futura Medical

Market Cap: UK£11.9m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

IXICO

Market Cap: UK£11.4m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

OptiBiotix Health

Market Cap: UK£10.6m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

Verici Dx

Market Cap: UK£9.8m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

Theracryf

Market Cap: UK£5.1m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

Incanthera

Market Cap: UK£4.1m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

BSF Enterprise

Market Cap: UK£3.4m

Develops and commercializes cutting-edge tissue-engineered solutions.

Roquefort Therapeutics

Market Cap: UK£3.3m

A material biotech company, engages in the development of medicines for the treatment of cancer.

genedrive

Market Cap: UK£1.6m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Physiomics

Market Cap: UK£1.5m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.